The emerging approach of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide119745.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69055275